ADAPT NXT: Fixed Cycles or Every‐Other‐Week IV Efgartigimod in Generalized Myasthenia Gravis

Συγγραφείς: Ali A. Habib, Kristl G. Claeys, Vera Bril, Yessar Hussain, Kelly Gwathmey, Gregory Sahagian, Elena Cortés‐Vicente, Edward Brauer, Deborah Gelinas, Anne Sumbul, Rosa H. Jimenez, Daniela Hristova, Delphine Masschaele, Renato Mantegazza, Andreas Meisel, Shahram Attarian, the ADAPT NXT Study Group

Πηγή: Ann Clin Transl Neurol
Annals of Clinical and Translational Neurology, Vol 12, Iss 6, Pp 1162-1170 (2025)

Θεματικοί όροι: Male, Adult, ADAPT NXT Study Group, Clinical Neurology, MULTICENTER, Neurosciences. Biological psychiatry. Neuropsychiatry, myasthenia gravis activities of daily living, Drug Administration Schedule, Myasthenia Gravis, Activities of Daily Living, MANAGEMENT, Humans, generalized myasthenia gravis, RC346-429, Aged, Science & Technology, neonatal Fc receptor, Neurosciences, 1103 Clinical Sciences, Middle Aged, EFFICACY, 5203 Clinical and health psychology, INTERNATIONAL CONSENSUS GUIDANCE, Treatment Outcome, SAFETY, 3209 Neurosciences, efgartigimod, Female, Neurosciences & Neurology, Neurology. Diseases of the nervous system, 1109 Neurosciences, Life Sciences & Biomedicine, RC321-571, Research Article

Σύνδεσμος πρόσβασης: https://pubmed.ncbi.nlm.nih.gov/40223516
https://doaj.org/article/579ed22d30e9489ea039ace6079d6d15
https://lirias.kuleuven.be/handle/20.500.12942/769529
https://doi.org/10.1002/acn3.70051

Recommendations for the management of myasthenia gravis in Belgium

Συγγραφείς: De Bleecker, Jan L, Remiche, Gauthier, Alonso-Jiménez, Alicia, Van Parys, Vinciane, Bissay, Véronique, DELSTANCHE, Stéphanie, Claeys, Kristl G

Συνεισφορές: Janssen Pharmaceutica, UCL - SSS/IONS/NEUR - Clinical Neuroscience, UCL - (SLuc) Service de neurologie, Neuroprotection & Neuromodulation, Clinical sciences, Neurology

Πηγή: Acta Neurol Belg
Acta neurologica Belgica, Vol. 124, no.4, p. 1371-1383 (2024)
Acta neurologica Belgica

Θεματικοί όροι: Clinical Neurology, Guideline, Sciences de la santé humaine, DOUBLE-BLIND, 03 medical and health sciences, 0302 clinical medicine, ECULIZUMAB, Belgium, Neurologie, Myasthenia Gravis, Humans, Human health sciences, Treatment recommendations, Myasthenia gravis, Science & Technology, Neurology & Neurosurgery, Clinical management, Myasthenia Gravis/diagnosis, Neurosciences, 3202 Clinical sciences, Disease Management, 1103 Clinical Sciences, EFFICACY, INTERNATIONAL CONSENSUS GUIDANCE, 3. Good health, PREGNANCY, Neurology, SAFETY, Therapies, 3209 Neurosciences, Practice Guidelines as Topic, Human medicine, Myasthenia Gravis/therapy, Neurology (clinical), Neurosciences & Neurology, Practice Guidelines as Topic/standards, 1109 Neurosciences, Life Sciences & Biomedicine

Περιγραφή αρχείου: 1 full-text file(s): application/pdf

Σύνδεσμος πρόσβασης: https://pubmed.ncbi.nlm.nih.gov/38649556
https://hdl.handle.net/2078.1/293807
https://repository.uantwerpen.be/docstore/d:irua:23651
https://hdl.handle.net/10067/2060290151162165141
https://biblio.vub.ac.be/vubir/recommendations-for-the-management-of-myasthenia-gravis-in-belgium(1b91b9a5-7124-4a65-8c48-93f766dc4d92).html

Effects of comorbid diseases on clinical outcomes in patients with myasthenia gravis

Συγγραφείς: Huseyin Nezih Ozdemir, Hatice Karasoy, Ayse Nur Yuceyar, Ozgul Ekmekci

Πηγή: Neurological Sciences. 44:2923-2931

Θεματικοί όροι: Male, Thymoma, Autoimmune-Diseases, MGFA, Thymus Neoplasms, Comorbid diseases, International Consensus Guidance, Thymectomy, Antibodies, 3. Good health, Management, Cross-Sectional Studies, Treatment Outcome, Myasthenia Gravis, Humans, Female, Myasthenia gravis, Outcome, Retrospective Studies

Σύνδεσμος πρόσβασης: https://pubmed.ncbi.nlm.nih.gov/36943588
https://hdl.handle.net/11454/89507
https://doi.org/10.1007/s10072-023-06750-8
https://hdl.handle.net/11454/101905
https://doi.org/10.1007/s10072-023-06750-8